Arcadia Biosciences (RKDA) Misses Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts RKDA Hot Sheet
Join SI Premium – FREE
Arcadia Biosciences (NASDAQ: RKDA) reported Q4 EPS of ($0.09), $0.02 worse than the analyst estimate of ($0.07).
For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2026 Financial Results and Business Highlights
- SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
